Focus: Heidelberg Pharma is a German-based public company focused on diagnostic and therapeutic products for oncology. Limited data available on current scale and market position.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Heidelberg Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Heidelberg Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Heidelberg Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Heidelberg Pharma FY 2025 slides: restructuring cuts 75% of staff - Investing.com
Heidelberg Pharma FY 2025 slides: restructuring cuts 75% of staff Investing.com
Earnings call transcript: Heidelberg Pharma Q4 2025 reveals strategic shifts - Investing.com
Earnings call transcript: Heidelberg Pharma Q4 2025 reveals strategic shifts Investing.com
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles